Detalles de la búsqueda
1.
Efficacy and safety of EGFR-TKIs in combination with angiogenesis inhibitors as first-line therapy for advanced EGFR-mutant non-small-cell lung cancer: a systematic review and meta-analysis.
BMC Pulm Med;
23(1): 207, 2023 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37316870
Resultados
1 -
1
de 1
1
Próxima >
>>